ID 201951094 · FY 2017–2024 · 8 years
Group parent — controls 2 companies
Medinservi (სს კომპანია მედინსერვი) — a mid-size Georgian pharmaceutical importer/distributor (joint-stock company, ~196 employees). Revenue ~GEL 16–19m through 2017–2022, tapering toward 2024; ranked among Georgia's top-10 pharmaceutical importers (ranked ~9th by import value in 2010). A wholesale/import distributor, not a retail pharmacy.
curated 2026-06-25reportal.ge
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16,443 | 16,491 | 16,089 | 18,325 | 19,735 | 19,212 | 14,474 | 8,753 | -8.6% |
| Total COGS | 0 | 0 | -10,972 | -12,127 | -13,313 | -14,138 | -8,013 | -4,992 | -14.6% |
| Gross Profit | 16,443 | 16,491 | 5,117 | 6,198 | 6,422 | 5,074 | 6,461 | 3,761 | -19.0% |
| Gross Margin | 100.0% | 100.0% | 31.8% | 33.8% | 32.5% | 26.4% | 44.6% | 43.0% | |
| Total Operating Expenses | -1,464 | -3,544 | -3,560 | -3,582 | -2,856 | -2,520 | -1,965 | -2,223 | +6.1% |
| EBITDA | 14,978 | 12,947 | 1,556 | 2,616 | 3,566 | 2,554 | 4,496 | 1,538 | -27.8% |
| EBITDA Margin | 91.1% | 78.5% | 9.7% | 14.3% | 18.1% | 13.3% | 31.1% | 17.6% | |
| Total D&A | -238 | -226 | -412 | -415 | -511 | -399 | -378 | -362 | +6.2% |
| EBIT / Operating Income | 14,741 | 12,721 | 1,144 | 2,201 | 3,055 | 2,155 | 4,118 | 1,177 | -30.3% |
| Total Interest Expense | -273 | -157 | 0 | 0 | 0 | 0 | 0 | 0 | -42.3% |
| Total Other Income | -481 | -545 | 555 | -1,077 | -512 | -1,055 | 169 | -494 | +0.4% |
| Profit Before Tax | 13,988 | 12,019 | 1,699 | 1,124 | 2,542 | 1,099 | 4,287 | 683 | -35.0% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 704 | 589 | 1,517 | 995 | 2,468 | 864 | 4,213 | 622 | -1.8% |
| Net Margin | 4.3% | 3.6% | 9.4% | 5.4% | 12.5% | 4.5% | 29.1% | 7.1% |
Ownership & directors from companyinfo.ge (public corporate registry).